COPD Trial, Recruiting NCT06702696 Sponsor: Amasya University Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT06702696
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 50 and 80 years old
  • You have been diagnosed with COPD (a lung condition)
  • You do not follow a vegetarian or vegan diet
  • You are willing to eat the aronia berry (also called black chokeberry) provided by the trial
  • You are a non-smoker
  • You are willing to sign a consent form agreeing to take part
  • You have not had a procedure involving tubes or valves placed in your airways in the last two years

Who may not be able to join:

  • You have a long-term inflammatory or rheumatic disease (such as rheumatoid arthritis or similar conditions)
  • You have a long-term infection that may affect your blood's ability to clot properly (confirm with trial site)
  • You have chronic kidney disease
  • You have or have had cancer
  • You have an inherited condition that makes your blood more likely to clot (confirm with trial site)
  • You have a condition called essential thrombocythemia, which involves having too many platelets in the blood
  • You have a diagnosed hormonal or endocrine disorder (such as thyroid disease or diabetes) (confirm with trial site)
  • You have a condition that affects how your body absorbs food or nutrients
  • You have an allergy to any food or berry fruits
  • You are a current smoker
  • You are not willing to sign the consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 05544615101

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Amasya University
Registry
ClinicalTrials.gov
Start date
15 November 2024
Est. completion
15 September 2025

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

C-Reactive Protein (CRP); Tumor Necrosis Factor-Alpha (TNF-Alpha); Interleukin-1 Beta (IL-1β); Interleukin-6 (IL-6); Interleukin-8 (IL-8); Interleukin-10 (IL-10); Total Antioxidant Status (TAS); Total Oxidant Status (TOS); The Oxidative Stress Index (OSI); COPD Assessment Test (CAT)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov